Cargando…

Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies

Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahayel, Shady, Tremblay, Christina, Vo, Andrew, Misic, Bratislav, Lehéricy, Stéphane, Arnulf, Isabelle, Vidailhet, Marie, Corvol, Jean-Christophe, Gagnon, Jean-François, Postuma, Ronald B, Montplaisir, Jacques, Lewis, Simon, Matar, Elie, Ehgoetz Martens, Kaylena, Borghammer, Per, Knudsen, Karoline, Hansen, Allan K, Monchi, Oury, Gan-Or, Ziv, Dagher, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393413/
https://www.ncbi.nlm.nih.gov/pubmed/36826230
http://dx.doi.org/10.1093/brain/awad044
_version_ 1785083152145842176
author Rahayel, Shady
Tremblay, Christina
Vo, Andrew
Misic, Bratislav
Lehéricy, Stéphane
Arnulf, Isabelle
Vidailhet, Marie
Corvol, Jean-Christophe
Gagnon, Jean-François
Postuma, Ronald B
Montplaisir, Jacques
Lewis, Simon
Matar, Elie
Ehgoetz Martens, Kaylena
Borghammer, Per
Knudsen, Karoline
Hansen, Allan K
Monchi, Oury
Gan-Or, Ziv
Dagher, Alain
author_facet Rahayel, Shady
Tremblay, Christina
Vo, Andrew
Misic, Bratislav
Lehéricy, Stéphane
Arnulf, Isabelle
Vidailhet, Marie
Corvol, Jean-Christophe
Gagnon, Jean-François
Postuma, Ronald B
Montplaisir, Jacques
Lewis, Simon
Matar, Elie
Ehgoetz Martens, Kaylena
Borghammer, Per
Knudsen, Karoline
Hansen, Allan K
Monchi, Oury
Gan-Or, Ziv
Dagher, Alain
author_sort Rahayel, Shady
collection PubMed
description Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson’s disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49–87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41–88) years; 77% men] with T(1)-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain’s structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer’s disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain’s structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer’s disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks.
format Online
Article
Text
id pubmed-10393413
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103934132023-08-02 Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies Rahayel, Shady Tremblay, Christina Vo, Andrew Misic, Bratislav Lehéricy, Stéphane Arnulf, Isabelle Vidailhet, Marie Corvol, Jean-Christophe Gagnon, Jean-François Postuma, Ronald B Montplaisir, Jacques Lewis, Simon Matar, Elie Ehgoetz Martens, Kaylena Borghammer, Per Knudsen, Karoline Hansen, Allan K Monchi, Oury Gan-Or, Ziv Dagher, Alain Brain Original Article Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson’s disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49–87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41–88) years; 77% men] with T(1)-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain’s structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer’s disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain’s structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer’s disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks. Oxford University Press 2023-02-24 /pmc/articles/PMC10393413/ /pubmed/36826230 http://dx.doi.org/10.1093/brain/awad044 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Rahayel, Shady
Tremblay, Christina
Vo, Andrew
Misic, Bratislav
Lehéricy, Stéphane
Arnulf, Isabelle
Vidailhet, Marie
Corvol, Jean-Christophe
Gagnon, Jean-François
Postuma, Ronald B
Montplaisir, Jacques
Lewis, Simon
Matar, Elie
Ehgoetz Martens, Kaylena
Borghammer, Per
Knudsen, Karoline
Hansen, Allan K
Monchi, Oury
Gan-Or, Ziv
Dagher, Alain
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title_full Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title_fullStr Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title_full_unstemmed Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title_short Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
title_sort mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393413/
https://www.ncbi.nlm.nih.gov/pubmed/36826230
http://dx.doi.org/10.1093/brain/awad044
work_keys_str_mv AT rahayelshady mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT tremblaychristina mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT voandrew mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT misicbratislav mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT lehericystephane mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT arnulfisabelle mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT vidailhetmarie mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT corvoljeanchristophe mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT gagnonjeanfrancois mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT postumaronaldb mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT montplaisirjacques mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT lewissimon mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT matarelie mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT ehgoetzmartenskaylena mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT borghammerper mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT knudsenkaroline mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT hansenallank mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT monchioury mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT ganorziv mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT dagheralain mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies
AT mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies